// App-Quantinova.ai

867 : Final Results of PUPs B-LONG Study: Evaluating Safety and Efficacy of rFIXFc in Previously Untreated Patients with Haemophilia B

Researchers

Presenter

  • Beatrice Nolan

Principal Investigators

  • Anna Klukowska

  • Amy D Shapiro

  • Antoine Rauch

  • Michael Recht

  • Margaret V. Ragni

  • Julie Curtin

  • Sriya Gunawardena

  • Stacey Poloskey

  • Deepthi Jayawardene

  • Bent Winding

  • Kathelijn Fischer

  • Raina Liesner

Medical Centers

  • Children's Health Ireland at Crumlin Dublin 2 Ireland

  • Medical University of Warsaw, Warsaw, Poland

  • Indiana Hemophilia & Thrombosis Center, Indianapolis, IN

  • Lille University Hospital Center (CHU) Lille, Lille, France

  • Oregon Health and Science University, Portland, OR

  • University of Pittsburgh Medical Center, Pittsburgh, PA

  • Children Hospital at Westmead, Sydney, Australia

  • Sanofi, Waltham, MA.

  • Swedish Orphan Biovitrum AB, Stockholm, Sweden

  • University Medical Center Utrecht, Utrecht, Netherlands

  • Great Ormond Street Hospital, London, United Kingdom

Locations

  • Ireland

  • Poland

  • United States

  • France

  • Australia

  • Sweden

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Open Label

  • Multinational

  • Multicenteric

Phase

  • III

Study Id's

  • NCT02234310

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved